ALLMedicine™ Hyperparathyroidism Center

Sep 26th, 2021 - Hyperparathyroidism (HPT) is a common disorder. A cure can only be achieved by removing all diseased glands. It is critical to localize the hyperfunctioning glands exactly to prevent extensive surgical exploration. The number of false negative/inc...

Sep 25th, 2021 - Brown tumor is a reactive osteolytic lesion associated with hyperparathyroidism and an extremely rare form of a single lesion in the maxilla. We report the case of a 57-year-old woman with renal dysfunction, nasal obstruction, and hypercalcemia. M...

Sep 25th, 2021 - Primary hyperparathyroidism (PHPT) is a common endocrine disorder and the most frequent benign cause of hypercalcemia. PHPT is characterized by autonomous hypersecretion of parathyroid hormone (PTH), regardless of serum calcium levels. Familial hy...

Sep 22nd, 2021 - This study aimed to evaluate a new 16-slice SPECT/CT scanner at Auckland City Hospital for its use in the detection and localization of parathyroid adenomas in patients with primary, secondary and tertiary hyperparathyroidism. The secondary outcom...

Sep 21st, 2021 - Genetic, symptomatic, and biochemical heterogeneity of patients with primary hyperparathyroidism (PHPT) has become apparent in recent years. An in-depth, evidence-based review of the phenotypes of PHPT was conducted. This review was intended to pr...

Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...

Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...

Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,

Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...

Apr 26th, 2021 - Hyperphosphatemia or abnormally high serum phosphate levels, has been identified as a key factor associated with cardiovascular complications and increased mortality risk among patients with chronic kidney disease (CKD). Hyperphosphatemia is a lat...

Mar 19th, 2021 - Burned by the offer of a special issue, a journal has retracted four papers after determining that the guest editors of the supplement were not legit.  Neuroscience Letters, an Elsevier title, published the special issue — "Special Issue on Clinic...

Jan 15th, 2021 - NEW YORK (Reuters Health) - Fewer than a third of elderly Medicare beneficiaries who may benefit from parathyroidectomy because of primary hyperparathyroidism (PHPT) actually receive such treatment, according to a population-based cohort study. As...

Aug 11th, 2020 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Aug 3rd, 2020 - Repeat bone mineral density (BMD) testing did not improve fracture-risk prediction in a large prospective cohort of postmenopausal women beyond baseline BMD measurement alone, according to new 12-year follow-up data. On the basis of the findings, ...